Lurasidone Market was valued at USD 2.5 Billion in 2022 and is projected to reach USD 3.5 Billion by 2030, growing at a CAGR of 5% from 2024 to 2030.
The global Lurasidone market has seen remarkable growth between 2018 and 2022, driven by increasing demand for psychiatric treatments, particularly for schizophrenia and bipolar depression. The drug, marketed under the brand name Latuda, gained popularity due to its relatively favorable side effect profile compared to other antipsychotic medications. Its effectiveness in managing both negative and positive symptoms of schizophrenia, along with its mood-stabilizing properties, made it a preferred choice for clinicians and patients alike. During this period, the market witnessed steady growth across major pharmaceutical markets, especially in North America, Europe, and parts of Asia.
By 2022, the Lurasidone market was already experiencing a steady rise in revenue, with various patent protections and clinical studies supporting its efficacy in both acute and maintenance treatments. Despite this, the competition from generic antipsychotics and newer treatments introduced by rival companies placed constraints on market growth. Nevertheless, Lurasidone's broadening indications and acceptance in psychiatric guidelines bolstered its standing. Furthermore, increasing healthcare spending in emerging economies contributed to greater accessibility to treatments, expanding the drug's market penetration.
The demand for Lurasidone from 2023 to 2033 is expected to undergo a significant shift. With patents expiring and generics entering the market, the drug’s price is expected to drop, making it more affordable for patients, particularly in low- and middle-income countries. As a result, the drug’s market share in these regions is projected to increase. Additionally, ongoing clinical research into Lurasidone’s use for other psychiatric conditions beyond schizophrenia and bipolar disorder could further propel demand. With several new indications potentially in the pipeline, this could open the door to broader patient populations and increased usage in mental health care.
Over the next decade, the market is also expected to experience a shift towards personalized medicine, with pharmaceutical companies focusing on optimizing treatment protocols for individual patients. This trend could drive the adoption of Lurasidone among patients who have specific genetic profiles or co-occurring mental health conditions that may benefit from its therapeutic effects.
Despite the potential for increased market competition, the Lurasidone market is forecasted to continue its growth trajectory. As healthcare systems evolve, especially in developing regions, the increased availability and affordability of antipsychotic drugs like Lurasidone will contribute to a larger patient base and stronger market demand.
Get an In-Depth Research Analysis of the Global Lurasidone Market Size And Forecast [2025-2032]
Angelini Holding S.p.A.
Sumitomo Dainippon Pharma Co.
Ltd.
RemedyRepack，Inc.
Bushu Pharmaceutical
LTD.
Zhejiang Hisun Pharmaceutical Co.
Ltd.
Healthcare Pharmaceuticals Limited
Square Pharmaceuticals Ltd.
Incepta Pharmaceuticals Ltd.
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Lurasidone Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Lurasidone Market
Hospital
Psychological Clinic
Others
Based on Types the Market is categorized into Below types that held the largest Lurasidone market share In 2023.
20mg/tablet
40mg/tablet
60mg/tablet
80mg/tablet
120mg/tablet
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Lurasidone Market Research Analysis
1. Introduction of the Global Lurasidone Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Lurasidone Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Lurasidone Market, By Type
6. Global Lurasidone Market, By Application
7. Global Lurasidone Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Lurasidone Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/